Yeyan Zhang
Profile
Yeyan Zhang is President of Dynal Biotech Ltd.
He was a Director of Welichem Biotech, Inc. until October 6, 2008.
Dr. Zhang received a BS from Huazhong Agricultural University, an MBA from the University of Chicago and a PhD from Simon Fraser University.
Former positions of Yeyan Zhang
| Companies | Position | End |
|---|---|---|
Welichem Biotech, Inc.
 Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Director/Board Member | 06/10/2008 |
Training of Yeyan Zhang
| Simon Fraser University | Doctorate Degree |
| The University of Chicago | Masters Business Admin |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Welichem Biotech, Inc.
Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
- Stock Market
- Insiders
- Yeyan Zhang
